79 related articles for article (PubMed ID: 14506684)
1. Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells.
Falcieri E; Burattini S; Bortul R; Luchetti F; Tabellini G; Tazzari PL; Cappellini A; Cocco L; Martelli AM
Microsc Res Tech; 2003 Oct; 62(3):192-200. PubMed ID: 14506684
[TBL] [Abstract][Full Text] [Related]
2. Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix.
Neri LM; Bortul R; Zweyer M; Tabellini G; Borgatti P; Marchisio M; Bareggi R; Capitani S; Martelli AM
J Cell Biochem; 1999 Jun; 73(3):342-54. PubMed ID: 10321834
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
4. Nuclear changes in necrotic HL-60 cells.
Bortul R; Zweyer M; Billi AM; Tabellini G; Ochs RL; Bareggi R; Cocco L; Martelli AM
J Cell Biochem Suppl; 2001; Suppl 36():19-31. PubMed ID: 11455567
[TBL] [Abstract][Full Text] [Related]
5. Human topoisomerase IIalpha nuclear export is mediated by two CRM-1-dependent nuclear export signals.
Turner JG; Engel R; Derderian JA; Jove R; Sullivan DM
J Cell Sci; 2004 Jun; 117(Pt 14):3061-71. PubMed ID: 15173319
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin.
Yamochi T; Yamochi T; Aytac U; Sato T; Sato K; Ohnuma K; McKee KS; Morimoto C; Dang NH
Cancer Res; 2005 Mar; 65(5):1973-83. PubMed ID: 15753397
[TBL] [Abstract][Full Text] [Related]
7. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs.
Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB
Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia.
Uggla B; Tina E; Nahi H; Paul C; Höglund M; Sirsjö A; Tidefelt U
Int J Oncol; 2007 Jul; 31(1):153-60. PubMed ID: 17549416
[TBL] [Abstract][Full Text] [Related]
9. Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus.
Scheller C; Knöferle J; Ullrich A; Prottengeier J; Racek T; Sopper S; Jassoy C; Rethwilm A; Koutsilieri E
J Cell Biochem; 2006 Apr; 97(6):1350-61. PubMed ID: 16365881
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents.
Skladanowski A; Côme MG; Sabisz M; Escargueil AE; Larsen AK
Mol Pharmacol; 2005 Sep; 68(3):625-34. PubMed ID: 15942022
[TBL] [Abstract][Full Text] [Related]
11. Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis.
Coss A; Tosetto M; Fox EJ; Sapetto-Rebow B; Gorman S; Kennedy BN; Lloyd AT; Hyland JM; O'Donoghue DP; Sheahan K; Leahy DT; Mulcahy HE; O'Sullivan JN
Cancer Lett; 2009 Apr; 276(2):228-38. PubMed ID: 19111388
[TBL] [Abstract][Full Text] [Related]
12. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and proteomics approaches to characterize topoisomerase IIalpha cysteines and DNA as targets responsible for cisplatin-induced inhibition of topoisomerase IIalpha.
Hasinoff BB; Wu X; Krokhin OV; Ens W; Standing KG; Nitiss JL; Sivaram T; Giorgianni A; Yang S; Jiang Y; Yalowich JC
Mol Pharmacol; 2005 Mar; 67(3):937-47. PubMed ID: 15602006
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 participates in DNA decatenation.
Lou Z; Minter-Dykhouse K; Chen J
Nat Struct Mol Biol; 2005 Jul; 12(7):589-93. PubMed ID: 15965487
[TBL] [Abstract][Full Text] [Related]
15. A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIalpha in vivo.
Grauslund M; Thougaard AV; Füchtbauer A; Hofland KF; Hjorth PH; Jensen PB; Sehested M; Füchtbauer EM; Jensen LH
Mol Pharmacol; 2007 Oct; 72(4):1003-14. PubMed ID: 17622580
[TBL] [Abstract][Full Text] [Related]
16. Comparative characterization of cell death between Sf9 insect cells and hybridoma cultures.
Meneses-Acosta A; Mendonça R; Merchant H; Covarrubias L; Ramírez O
Biotechnol Bioeng; 2001 Feb; 72(4):441-57. PubMed ID: 11180064
[TBL] [Abstract][Full Text] [Related]
17. Behavior of nuclear matrix proteins during camptothecin-induced apoptosis in HL-60 human leukemia cells.
Zweyer M; Bareggi R; Grill V; Soranzo MR; Marugg RA; Riederer BM; Narducci P; Martelli AM
Exp Cell Res; 1995 Nov; 221(1):27-40. PubMed ID: 7589253
[TBL] [Abstract][Full Text] [Related]
18. Methods for distinguishing apoptotic from necrotic cells and measuring their clearance.
Krysko DV; Vanden Berghe T; Parthoens E; D'Herde K; Vandenabeele P
Methods Enzymol; 2008; 442():307-41. PubMed ID: 18662577
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase IIalpha inhibition following DNA transfection greatly enhances random integration in a human pre-B lymphocyte cell line.
Toyoda E; Kurosawa A; Kamekawa H; Adachi N
Biochem Biophys Res Commun; 2009 May; 382(3):492-6. PubMed ID: 19285952
[TBL] [Abstract][Full Text] [Related]
20. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
